Related Experiment Video
Updated: Aug 6, 2026
09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Immunology of platelet disorders
Bailliere'S Clinical Haematology
|July 1, 1989
Summary
Immune-mediated thrombocytopenias (IMTPs) involve antibodies attacking platelets, leading to bleeding disorders. Advances in platelet immunology offer better diagnostics and understanding of these conditions.
Area of Science:
- Hematology
- Immunology
- Clinical Medicine
Background:
- Immune-mediated thrombocytopenias (IMTPs) are common hemostatic disorders.
- IMTPs stem from allo-immunity, autoimmunity, or drug-induced immune mechanisms.
- Antibodies in IMTPs cause platelet destruction or hinder function.
Purpose of the Study:
- To review the immunopathogenesis of IMTPs.
- To highlight advancements in studying platelet antigens and antibodies.
- To underscore the significance of platelet immunology in diagnostics and research.
Main Methods:
- Review of existing literature on IMTPs.
- Analysis of antibody-mediated mechanisms in platelet destruction.
- Discussion of diagnostic methodologies for platelet antigens and antibodies.
Main Results:
- Platelet destruction or dysfunction is antibody-driven in IMTPs.
- Platelet antigens, often polymorphic integrin determinants, are key.
- Improved methodologies enhance diagnostic accuracy and understanding of IMTPs.
Conclusions:
- Platelet immunology is crucial for understanding and diagnosing IMTPs.
- Recent methodological improvements have significantly advanced the field.
- Platelet immunology remains a dynamic and evolving area of research.
Related Concept Videos
01:38Inflammation
Overview
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.